Niagen Bioscience, Inc. (NAGE)

CIK 1386570 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Niagen Bioscience, Inc..

Recent SEC filings

FiledFormAccession number
Aug 4, 20268-K0001386570-26-000042
Aug 4, 202610-Q0001386570-26-000043
Jul 29, 2026SCHEDULE 13G0002012383-26-002885
Jul 10, 2026424B50001213900-26-077234
Jul 9, 2026EFFECT9999999995-26-002240
Jul 8, 202640001417952-26-000002
Jul 8, 202640001834681-26-000001
Jul 8, 202640002042509-26-000001
Jun 29, 2026S-30001213900-26-072796
Jun 29, 20268-K0001386570-26-000035
Jun 26, 202640001381874-26-000001
Jun 26, 202640001713918-26-000001
Jun 26, 202640001923843-26-000001
Jun 26, 202640001769529-26-000003
Jun 26, 202640001896252-26-000001
Jun 26, 202640001942711-26-000001
Jun 26, 202640001437237-26-000001
May 6, 20268-K0001386570-26-000031
May 6, 202610-Q0001386570-26-000030
Apr 29, 2026ARS0001386570-26-000024
Apr 29, 2026DEF 14A0001386570-26-000022
Apr 29, 2026DEFA14A0001386570-26-000023
Apr 27, 202640001417952-26-000001
Mar 19, 20268-K0001386570-26-000017
Mar 4, 20268-K0001386570-26-000014